Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory M Lucas

Showing results (51-60 of 174) with videos related to

Pageof 18
Sort By:
AIDS (London, England)|April 20, 2004
Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort studyGregory M Lucas, Joseph A Eustace, Stephen Sozio, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 3, 2006
Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groupsGregory M Lucas, B Anna Mullen, Paul J Weidle, et al.
AIDS Patient Care and Stds|August 23, 2007
Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapyGregory M Lucas, B Anna Mullen, Mary E McCaul, et al.
Plos One|June 11, 2015
Outcomes of Renal Transplantation in HIV-1 Associated NephropathySana Waheed, Ahmad Sakr, Neha D Chheda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2006
Initial strategies for integrating buprenorphine into HIV care settings in the United StatesLynn E Sullivan, Robert D Bruce, David Haltiwanger, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 14, 2010
Role of HIV-1 DNA levels as clinical marker of HIV-1-associated nephropathiesHassane Izzedine, Veena Acharya, Marc Wirden, et al.
Clinical Kidney Journal|August 8, 2015
Proximal tubular dysfunction and kidney injury associated with tenofovir in HIV patients: a case seriesSana Waheed, Doaa Attia, Michelle M Estrella, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 15, 2008
Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, MarylandMohamed G Atta, Derek M Fine, Gregory D Kirk, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 14, 2009
Nonstructured treatment interruptions among injection drug users in Baltimore, MDRavi Kavasery, Noya Galai, Jacquie Astemborski, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 8, 2009
Predictors of complication after percutaneous ultrasound-guided kidney biopsy in HIV-infected individuals: possible role of hepatitis C and HIV co-infectionSayed Tabatabai, C John Sperati, Mohamed G Atta, et al.
Pageof 18

Showing results (51-60 of 174) with videos related to

Sort By:
Pageof 18
AIDS (London, England)|April 20, 2004
Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort studyGregory M Lucas, Joseph A Eustace, Stephen Sozio, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 3, 2006
Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groupsGregory M Lucas, B Anna Mullen, Paul J Weidle, et al.
AIDS Patient Care and Stds|August 23, 2007
Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapyGregory M Lucas, B Anna Mullen, Mary E McCaul, et al.
Plos One|June 11, 2015
Outcomes of Renal Transplantation in HIV-1 Associated NephropathySana Waheed, Ahmad Sakr, Neha D Chheda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2006
Initial strategies for integrating buprenorphine into HIV care settings in the United StatesLynn E Sullivan, Robert D Bruce, David Haltiwanger, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 14, 2010
Role of HIV-1 DNA levels as clinical marker of HIV-1-associated nephropathiesHassane Izzedine, Veena Acharya, Marc Wirden, et al.
Clinical Kidney Journal|August 8, 2015
Proximal tubular dysfunction and kidney injury associated with tenofovir in HIV patients: a case seriesSana Waheed, Doaa Attia, Michelle M Estrella, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 15, 2008
Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, MarylandMohamed G Atta, Derek M Fine, Gregory D Kirk, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 14, 2009
Nonstructured treatment interruptions among injection drug users in Baltimore, MDRavi Kavasery, Noya Galai, Jacquie Astemborski, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 8, 2009
Predictors of complication after percutaneous ultrasound-guided kidney biopsy in HIV-infected individuals: possible role of hepatitis C and HIV co-infectionSayed Tabatabai, C John Sperati, Mohamed G Atta, et al.
Pageof 18